Despite the United States Preventive Services Task Force (USPSTF) recommendations for annual lung cancer screening with low-dose computed tomography (LDCT) among at-risk patients, rates of screening remain low, according to an oral presentation to be presented at the...
Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer
Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of cancer death worldwide. Read the guidelines here
Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Although the reason why the disease develops remains unknown for many cancers, particularly those that occur...
Order yours now!
View the Webinar on YouTube. https://www.youtube.com/watch?time_continue=8&v=DWuEG7RVUkQ Click here for more information about AI/AN Lung Cancer screening